agilon health, inc. (NYSE:AGL) Shares Sold by Creative Planning

Creative Planning trimmed its position in shares of agilon health, inc. (NYSE:AGL) by 33.9% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 44,176 shares of the company’s stock after selling 22,648 shares during the period. Creative Planning’s holdings in agilon health were worth $174,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Capital International Investors lifted its stake in shares of agilon health by 84.7% in the 1st quarter. Capital International Investors now owns 20,197,932 shares of the company’s stock worth $123,207,000 after acquiring an additional 9,263,296 shares during the period. AQR Capital Management LLC lifted its stake in shares of agilon health by 3,338.5% in the 2nd quarter. AQR Capital Management LLC now owns 1,356,438 shares of the company’s stock worth $8,871,000 after acquiring an additional 1,316,990 shares during the period. Vanguard Group Inc. lifted its stake in shares of agilon health by 1.3% in the 1st quarter. Vanguard Group Inc. now owns 28,947,798 shares of the company’s stock worth $176,582,000 after acquiring an additional 371,537 shares during the period. Susquehanna Fundamental Investments LLC lifted its stake in shares of agilon health by 65.0% in the 2nd quarter. Susquehanna Fundamental Investments LLC now owns 804,594 shares of the company’s stock worth $5,262,000 after acquiring an additional 316,856 shares during the period. Finally, Healthcare of Ontario Pension Plan Trust Fund acquired a new stake in shares of agilon health in the 2nd quarter worth approximately $1,849,000.

Wall Street Analyst Weigh In

A number of research firms recently commented on AGL. Royal Bank of Canada reiterated an “outperform” rating and issued a $8.00 target price on shares of agilon health in a report on Wednesday, August 7th. Evercore ISI dropped their target price on shares of agilon health from $7.00 to $4.00 and set an “in-line” rating on the stock in a report on Tuesday, October 8th. TD Cowen dropped their target price on shares of agilon health from $6.00 to $2.00 and set a “hold” rating on the stock in a report on Monday. Bank of America downgraded shares of agilon health from a “buy” rating to an “underperform” rating and set a $3.00 target price on the stock. in a report on Wednesday, October 2nd. Finally, Deutsche Bank Aktiengesellschaft dropped their target price on shares of agilon health from $5.00 to $4.00 and set a “hold” rating on the stock in a report on Friday, August 9th. Three equities research analysts have rated the stock with a sell rating, fifteen have given a hold rating and three have given a buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $7.34.

agilon health Trading Up 17.4 %

Shares of AGL stock opened at $2.16 on Tuesday. agilon health, inc. has a 12-month low of $1.80 and a 12-month high of $13.76. The company has a market capitalization of $888.80 million, a P/E ratio of -2.30 and a beta of 0.60. The firm has a 50-day moving average price of $3.22 and a 200 day moving average price of $4.95. The company has a quick ratio of 1.36, a current ratio of 1.36 and a debt-to-equity ratio of 0.04.

agilon health (NYSE:AGL) last posted its quarterly earnings data on Thursday, November 7th. The company reported ($0.29) earnings per share for the quarter, missing the consensus estimate of ($0.10) by ($0.19). The company had revenue of $1.45 billion during the quarter, compared to analyst estimates of $1.47 billion. agilon health had a negative net margin of 6.88% and a negative return on equity of 46.06%. During the same quarter in the previous year, the business posted ($0.06) EPS. Research analysts forecast that agilon health, inc. will post -0.32 earnings per share for the current fiscal year.

Insider Transactions at agilon health

In other agilon health news, CEO Steven Sell purchased 20,000 shares of the stock in a transaction dated Thursday, September 12th. The stock was bought at an average price of $3.36 per share, for a total transaction of $67,200.00. Following the transaction, the chief executive officer now directly owns 67,590 shares in the company, valued at $227,102.40. This represents a 0.00 % increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available at the SEC website. 3.20% of the stock is owned by corporate insiders.

agilon health Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.